Childhood cancers trials in Sweden

In Sweden 65 Also abroad 2459

65 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Where
Gothenburg, Linköping, Stockholm, Umeå, Uppsala
Age
Up to 64 years
People
311 worldwide
Run by
The University Of Birmingham
See details and how to join2024-510578-25-00 · EU 2024-510578-25-00
Phase 2/3Taking people
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Where
Gothenburg, Huddinge, Lund, Uppsala
Age
1 month to 18 years
People
1,800 worldwide
Run by
St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00
No phaseTaking people
Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer
Where
Borås, Halmstad, Helsingborg, Jönköping, Karlskrona, Kristianstad, Lund, Malmö, Uppsala, Vaxjo
People
20,000
Run by
Lund University
See details and how to joinNCT02306096
No phaseTaking people
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Where
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
Age
0 years to 45 years
People
500 worldwide
Run by
Mats Heyman
See details and how to joinNCT03911128
No phaseTaking people
Cerebellar Mutism Syndrome Study
Where
Gothenburg, Linköping, Skåne, Stockholm, Umeå, Uppsala
Age
Up to 18 years
People
2,000 worldwide
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766
Phase 3Taking people
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Where
Goteborg, Gothenburg, Linkoping, Lund, Orebro, Stockholm, Umea, Uppsala
Age
0 years to 45 years
People
6,430 worldwide
Run by
Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01
Phase 2Taking people
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
Where
Gothenburg
Age
Up to 64 years
People
31 worldwide
Run by
Pediatric Research International GmbH
See details and how to join2025-521390-14-00 · EU 2025-521390-14-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Lund, Solna
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 3Taking people
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
Where
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
People
508 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-505575-69-01 · EU 2023-505575-69-01
Phase 1Taking people
International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
Where
Gothenburg
People
18 worldwide
Run by
GPOH gGmbH
See details and how to join2024-515245-42-00 · EU 2024-515245-42-00
Phase 1/2Taking people
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Where
Lund
Age
6 months to 17 years
People
370 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00
No phaseTaking people
Evaluation of a Psychosocial Support Model for Adolescents and Young Adults Newly Diagnosed With Cancer
Where
Gothenburg, Stockholm
Age
16 years and over
People
142
Run by
Karolinska Institutet
See details and how to joinNCT06979843
Phase 3Taking people
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Where
Gothenburg, Linkoping, Lund, Solna, Umea, Uppsala
Age
Up to 18 years
People
683 worldwide
Run by
University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00
Phase 2Taking people
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Where
Stockholm
Age
Up to 17 years
People
250 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00
Phase 2/3Taking people
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Where
Goteborg
Age
Up to 25 years
People
210 worldwide
Run by
University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00
No phaseTaking people
Biomarkers of Brain Injury in Children With Brain Tumors
Where
Uppsala
Age
Up to 17 years
People
560
Run by
Uppsala University
See details and how to joinNCT07381959
Phase 1/2Taking people
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Where
Gothenburg, Stockholm
Age
1 year to 64 years
People
160 worldwide
Run by
University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00
No phaseTaking people
International Leukemia Target Board
Where
Gothenburg
Age
0 years to 25 years
People
600 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05270096
No phaseTaking people
Medulloblastoma Online Video-based Exercise Pilot Study
Where
Gothenburg
Age
3 years to 18 years
People
15 worldwide
Run by
Aron Onerup
See details and how to joinNCT06898684
Phase 1/2Taking people
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Where
Gothenburg
Age
1 year to 25 years
People
65 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT04925609 · EU 2024-513412-10-00
No phaseEnrolling by invitation
Implant-Related Infections in Patients With Skeletal Sarcomas
Where
Gothenburg
People
40
Run by
Vastra Gotaland Region
See details and how to joinNCT07264296
Phase 1/2Taking people
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Where
Stockholm
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00
Phase 1/2Taking people
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Stockholm
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01
Phase 1/2Taking people
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Stockholm
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00
No phaseNot yet taking people in Sweden
A Digitally Distributed Yoga Intervention in Prostate Cancer Rehabilitation : Protocol for a Randomized Controlled Trial
Where
Örebro
People
220
Run by
Region Örebro County
See details and how to joinNCT07158138